Q&A With William Tierney From Regenstrief Institute: Results of Regenstrief Project Show Mixed Results

Video

When given the choice of what parts of their records patients wanted made available to healthcare professionals, the results showed a mixed reaction to the ability. There were also questions raised about the risks associated with only making the records available to certain people.

When given the choice of what parts of their records patients wanted made available to healthcare professionals, the results showed a mixed reaction to the ability. There were also questions raised about the risks associated with only making the records available to certain people.

William M. Tierney, MD, President and CEO of the Regenstrief Institute and a professor at Indiana University discussed the results of the project which included more than 105 patients in a clinic in the Eskenazi health system. Of that group 57% made their records completely open to doctors while 4 completely blocked their records.

Related Videos
Brendon Neuen, MBBS, PhD | Credit: X.com
Boadie Dunlop, MD, Weighs in on FDA Advisory Vote on Lykos’ MDMA
HCPLive Five at ADA 2024 | Image Credit: HCPLive
A Promising Pipeline for COPD
Projecting Dupilumab's Fit in COPD
What the Ensifentrine FDA Approval Means for COPD
Ralph DeFronzo, MD | Credit: UT San Antonio
Signs and Symptoms of Connective Tissue Disease
Timothy Garvey, MD | Credit: University of Alabama at Birmingham
Atul Malhotra, MD | Credit: Kyle Dykes; UC San Diego Health
© 2024 MJH Life Sciences

All rights reserved.